Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
President Trump has posted a new announcement on Truth Social, the social media platform. He wrote:
“‘Biggest thing in healthcare’ in decades: White House launches ‘TrumpRx’ to lower prescription drug prices:”
How Will Trump’s Statement Affect the Stock Market?
This latest post has the potential to affect the stock market. That’s because Trump’s announcement of “TrumpRx” to lower prescription drug prices could pressure major pharmaceutical names like Amgen (AMGN), Merck (MRK), and Pfizer (PFE), as investors may anticipate future margin compression and heightened pricing scrutiny. Broader healthcare funds such as the Health Care Select Sector SPDR Fund (XLV) and Vanguard Health Care ETF (VHT) could see short-term volatility as the market reassesses earnings expectations for drugmakers and related firms. The iShares Biotechnology ETF (IBB) might also experience weakness given its heavy exposure to biotech companies reliant on premium pricing, although some investors could later view any sell-off as a buying opportunity if policy details prove less disruptive than feared.
Here are some of the stocks that might be affected:
Amgen Inc ((AMGN)),
Merck & Company ((MRK)),
Pfizer Inc ((PFE)),
Health Care Select Sector SPDR Fund ((XLV)),
Vanguard Health Care ETF ((VHT)),
iShares Biotechnology ETF ((IBB)).